These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 16360246)

  • 61. Pulmonary consequences of transfusion: TRALI and TACO.
    Popovsky MA
    Transfus Apher Sci; 2006 Jun; 34(3):243-4. PubMed ID: 16872902
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Blood donor and component management strategies to prevent transfusion-related acute lung injury (TRALI).
    Mair DC; Hirschler N; Eastlund T
    Crit Care Med; 2006 May; 34(5 Suppl):S137-43. PubMed ID: 16617258
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antibodies to major histocompatibility complex class II antigens directly prime neutrophils and cause acute lung injury in a two-event in vivo rat model.
    Kelher MR; Banerjee A; Gamboni F; Anderson C; Silliman CC
    Transfusion; 2016 Dec; 56(12):3004-3011. PubMed ID: 27667662
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.
    Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ
    Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617
    [TBL] [Abstract][Full Text] [Related]  

  • 65. HLA class II antibodies in transfusion-related acute lung injury (TRALI). A case report.
    Lydaki E; Bolonaki E; Nikoloudi E; Chalkiadakis E; Iniotaki-Theodoraki A
    Transfus Apher Sci; 2005 Oct; 33(2):107-11. PubMed ID: 16115801
    [TBL] [Abstract][Full Text] [Related]  

  • 66. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma.
    Sachs UJ; Kauschat D; Bein G
    Transfusion; 2005 Oct; 45(10):1628-31. PubMed ID: 16181214
    [TBL] [Abstract][Full Text] [Related]  

  • 67. TRALI-new challenges for histocompatibility and immunogenetics in transfusion medicine.
    Flesch BK; Petershofen EK; Bux J
    Tissue Antigens; 2011 Jul; 78(1):1-7. PubMed ID: 21658007
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of anti-Nak(a) antibody, monocytes and platelets in the development of transfusion-related acute lung injury.
    Nakajima F; Nishimura M; Hashimoto S; Okazaki H; Tadokoro K
    Vox Sang; 2008 Nov; 95(4):318-23. PubMed ID: 19138262
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detection of anti-CD32 alloantibody in donor plasma implicated in development of transfusion-related acute lung injury.
    Nishimura M; Takanashi M; Okazaki H; Satake M
    Cell Biochem Funct; 2007; 25(2):179-83. PubMed ID: 16287215
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pulmonary edema after transfusion: how to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury.
    Gajic O; Gropper MA; Hubmayr RD
    Crit Care Med; 2006 May; 34(5 Suppl):S109-13. PubMed ID: 16617253
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Enhancement of endothelial permeability by coculture with peripheral blood mononuclear cells in the presence of HLA Class II antibody that was associated with transfusion-related acute lung injury.
    Wakamoto S; Fujihara M; Takahashi D; Niwa K; Sato S; Kato T; Azuma H; Ikeda H
    Transfusion; 2011 May; 51(5):993-1001. PubMed ID: 20977481
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Transfusion-related acute lung injury associated with an NA1-specific antigranulocyte antibody.
    Santamaría A; Moya F; Martinez C; Martino R; Martinez-Pérez J; Muñiz-Díaz E
    Haematologica; 1998 Oct; 83(10):951-2. PubMed ID: 9830807
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The divergent clinical presentations of transfusion-related acute lung injury illustrated by two case reports.
    Vlaar AP; Porcelijn L; van Rooijen-Schreurs IH; Lardy NM; Kersten MJ; Juffermans NP
    Med Sci Monit; 2010 Oct; 16(10):CS129-34. PubMed ID: 20885357
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transfusion therapy and acute lung injury.
    Sokolovic M; Pastores SM
    Expert Rev Respir Med; 2010 Jun; 4(3):387-93. PubMed ID: 20524921
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations.
    Odent-Malaure H; Quainon F; Ruyer-Dumontier P; Ducroz S; Verdier P; Voitellier E; Raynal MF; Fromont P; Muller JY; Rebibo D; Absi L; Garraud O
    Clin Dev Immunol; 2005 Dec; 12(4):243-8. PubMed ID: 16584109
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transfusion-related acute lung injury: a clinical challenge.
    Dennison CA
    Dimens Crit Care Nurs; 2008; 27(1):1-7; quiz 8-9. PubMed ID: 18091624
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study.
    Silliman CC; Paterson AJ; Dickey WO; Stroneck DF; Popovsky MA; Caldwell SA; Ambruso DR
    Transfusion; 1997 Jul; 37(7):719-26. PubMed ID: 9225936
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interference with TRALI-causing anti-HLA DR alloantibody induction of human pulmonary microvascular endothelial cell injury by purified soluble HLA DR.
    Nishimura M; Hashimoto S; Satake M; Okazaki H; Tadokoro K
    Vox Sang; 2007 Jul; 93(1):78-82. PubMed ID: 17547569
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A threshold model for the susceptibility to transfusion-related acute lung injury.
    Sachs UJ
    Transfus Clin Biol; 2012 Jun; 19(3):109-16. PubMed ID: 22677431
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dyspnoea due to plasma transfusion-related acute lung injury.
    Wong RK; Wai CT
    Singapore Med J; 2006 Oct; 47(10):904-6. PubMed ID: 16990969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.